GSK3B and endometrial cancer: Thus, metformin might promote a hyperactive state of GSK3-β in endometrial cancer cells, resulting in a further decrease in β-catenin protein and a drop in the transcription of TCF/LEF target genes, including the cell-cycle regulatory genes cyclin D1 and c-myc.